A randomized control trial of isoniazid to prevent tuberculosis in kidney transplant recipients living in an endemic area

Phase 3

• Conditions: TuberculosisImmunocompromised hostMortality; prevention, tuberculosis, kidney transplantation

• Registration Number: TCTR20200716001
• Lead Sponsor: Faculty of Medicine Ramathibodi Hospital, Mahidol University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-07-16
• Study Completion: 2021-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Adult kidney transplant recipients

Exclusion Criteria

Deny participation
Active TB at the time of enrollement
Allergic to isoniazid

Study & Design

• Study Type: Interventional
• Study Design: Not specified